Dolutegravir Use at Conception - Additional Surveillance Data from Botswana

N Engl J Med. 2019 Aug 29;381(9):885-887. doi: 10.1056/NEJMc1908155. Epub 2019 Jul 22.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Botswana / epidemiology
  • Female
  • Fetus / drug effects
  • HIV Infections / drug therapy*
  • HIV Integrase Inhibitors / adverse effects*
  • HIV Integrase Inhibitors / therapeutic use
  • Heterocyclic Compounds, 3-Ring / adverse effects*
  • Heterocyclic Compounds, 3-Ring / therapeutic use
  • Humans
  • Infant, Newborn
  • Neural Tube Defects / chemically induced*
  • Neural Tube Defects / epidemiology
  • Oxazines
  • Piperazines
  • Population Surveillance
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy*
  • Prevalence
  • Pyridones

Substances

  • HIV Integrase Inhibitors
  • Heterocyclic Compounds, 3-Ring
  • Oxazines
  • Piperazines
  • Pyridones
  • dolutegravir